Background Insulin resistance characterizes type 1 diabetes mellitus with nephropathy. The molecular mechanisms of insulin resistance are not completely understood. Recently some advances have been made in identification of transmembrane glycoprotein PC-1 as a potential factor of insulin resistance.
Introduction
Insulin resistance, manifest as impaired insulinstimulated glucose uptake in skeletal muscle and other key insulin target tissues, is a feature of type 2 (non-insulin-dependent) diabetes mellitus. 1 Insulin resistance characterizes type 1 (insulin-dependent) diabetes mellitus in patients with albuminuria and their non-diabetic ¢rst-degree relatives. 2, 3 The molecular mechanisms of insulin resistance are not completely understood. Recently some advances have been made in the identi¢cation of plasma cell di¡er-entiation antigen (PC-1), which is a class II transmembrane glycoprotein, as a potential factor in insulin resistance. 4 PC-1, which possesses multiple enzymatic activities (alkaline phosphodiesterase I, pyrophosphatase), is expressed in many tissues and inhibits insulin signalling either at the level of the insulin receptor or downstream at the level of S-6 kinase activity. 4, 5 PC-1 circulates in human plasma and its concentration is related to insulin sensitivity. 6 Urinary PC-1 was found to be mainly produced by the kidney. 7, 8 The aim of this study was to determine urinary PC-1 (measured as alkaline phosphodiesterase I activity) in patients with type 1 diabetes, from those newly detected with diabetes to those with diabetic nephropathy and renal failure. N-Acetyl-b-D-glucosaminidase (NAGA), a lysosomal enzyme, was determined as an established marker of kidney damage.
Methods
Sixty-two type 1diabetes patients (28 men, 34 women) and 12 patients with primary glomerulonephritis participated in the study, after informed consent was obtained. Five groups of patients with type 1 diabetes were studied: patients with newly diagnosed diabetes Original Article before the introduction of insulin treatment; patients without kidney damage; patients with microalbuminuria ; patients with macroalbuminuria; and patients with diabetic nephropathy and renal failure. A control group of 24 non-diabetic subjects (11men, 13 women) was studied. These individuals had no personal history of diabetes or ¢rst-degree relative with diabetes. Timed ¢rst morning urine and blood samples with and without EDTA for plasma and serum analyses were collected. Urine was immediately frozen at 7208C until PC-1 measurement.
Urinary PC-1 enzymatic activity
The phosphodiesterase activity of PC-1 was measured by the hydrolysis of thymidine 5'-monophosphate pnitrophenyl ester (Sigma Chemical Co., St Louis, MO, USA). 8 The substrate (5 mM) was pre-incubated in 0¢5 mL of 50 mM Tris -HCl bu¡er, pH 8¢5, 130 mM NaCl and 1mM MgCl 2 . The reaction was started by addition of 0¢1mL of centrifuged urine and carried out at 378C for 3-10 min with gentle agitation, under zero-order kinetic conditions. The enzyme reaction was stopped with 0¢1mL of 1 M NaOH. The p-nitrophenol formed was measured at 405 nm. The interassay percentage coe¤cient of variation of this assay was 4¢4.
Urine NAGA activity
NAGA activity was determined according to the method of Horak et al. 9 The inter-assay percentage coe¤cient of variation for this assay was 5¢2.
Other methods
Urinary protein was measured by the Ponceau S technique 10 and albumin was determined by a commercial radioimmunoas say kit from Phadebas (Uppsala, Sweden). 11 The inter-assay percentage coe¤cients of variation were 6¢5 and 5¢7 for protein and albumin, respectively. Microalbuminuria was de¢ned as urinary albumin excretion of 20 -200 mg/min. Macroalbuminuria was de¢ned as urinary albumin excretion 4200 mg/min or total urinary protein excretion 40 ¢5 g per 24 h. Serum creatinine was estimated by an autoanalyser technique (Astra 8, Beckman). Mean (standard deviation) values are given. Statistical di¡erence between groups was estimated using Student's t-test.
Urinary enzyme/creatinine ratios were calculated. Median (range) PC-1and NAGAactivities are expressed per mmol of urinary creatinine. Comparisons of enzyme activity between di¡erent groups were carried out using the Mann-Whitney U-test, and di¡erences were considered signi¢cant at P50 ¢05.
Results
The mean age of the diabetic patients was 40¢9 years (range 21-66), the lowest being 22¢3 years in newly diagnosed patients. The mean age of patients with primary glomerulonephritis was 44 ¢ 3 years (range 18-63) and the mean age in the control group was 42¢3 years (range 18-65). The duration of diabetes was lowest in newly detected cases, for which it was only a few days; however, it increased to 20¢8 years in diabetics with renal failure (see Table 1 ).
Urinary PC-1 activity
In newly detected type 1 diabetes patients, median urinary PC-1 activity was signi¢cantly increased over the controls (0¢398 versus 0¢240 U/mmol creatinine; P50 ¢05) (see Table 1 ). However, in diabetic patients without nephropathy, the median urine PC-1 activity was signi¢cantly lower than controls (P50¢05), as it was in patients with microalbuminuria, diabetic nephropathy and in diabetics with renal failure. Urinary PC-1 activity in patients with primary glomerulonephritis was also signi¢cantly decreased compared to healthy controls (P50 ¢ 05).
Urinary NAGA activity
The median value of urinary NAGA activity was signi¢cantly (P50 ¢ 001) increased in newly detected type 1 diabetes patients compared to healthy controls (1¢400 versus 0¢808 U/mmol creatinine). In diabetic patients without kidney damage, urinary NAGA was slightly but not signi¢cantly increased, with a maximal excretion of 4¢468 U/mmol and a level over the upper limit of control in 25% of patients. In patients with microalbuminuria and manifest diabetic nephropathy, including patients with renal failure, the NAGA level was signi¢cantly (P50 ¢ 001) increased over control. The highest increase was recorded in patients with primary glomerulonephritis (P50¢001).
Discussion
This study has established signi¢cantly increased urinary PC-1 (alkaline phosphodiesterase I) excretion in newly detected type 1 diabetes patients, just before institution of insulin therapy. Urinary NAGA excretion was also increased in these patients, associated with poor glycaemic control. In previous studies, urinary NAGA was found to be responsive to acute changes in blood glucose 12 and to correlate positively with the mean blood glucose level over 7 days before the collection of urine (r=0¢47).
13
In patients with type 1 diabetes without apparent kidney damage, as estimated by normal urinary albumin excretion, as well as in diabetic patients with microalbuminuria and diabetic nephropathy, urinary PC-1 excretion was signi¢cantly (P50¢05) decreased compared to that of controls. Urinary PC-1 is mainly due to renal metabolism and probably only partly originates from serum. 7 Decreased PC-1 excretion can not simply be attributed to diminished kidney function as it is observed in patients with both hyper-and hypo¢ltration. The exact mechanism of decreased urinary PC-1 excretion in type1 diabetes remains to be established.
Urinary NAGA excretion in patients with microalbuminuria and diabetic nephropathy was signi¢-cantly increased. In diabetic patients without apparent kidney damage, no statistically signi¢cant di¡erence in excretion was observed in present study; however, an increased urinary NAGA excretion was found in 25% of patients. A study of Jones et al. has established that measurement of NAGA excretion in diabetes indicates renal tubular dysfunction or damage before any signi¢cant change in albumin excretion rate. 14 The predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes has been studied over a period of 7¢5 years, and 50% of those patients with both an elevated NAGA excretion and an increased HbA 1c developed microalbuminuria within the next 5 years. 15 However, a recent study suggests that raised amounts of urinary retinol-binding protein and NAGA are related to HbA 1c and the duration of diabetes, and are not early markers for the risk of microalbuminuria. 16 Kidney is an organ rich in pyrophosphatase/phosphodiesterase activity both in humans and in rat. 8 An ectonucleotide pyrophosphatase has been found in the brush border of the proximal tubule; however, a highly active phosphodiesterase I was demonstrated in glomerular epithelial and mesangial cells.
17^19 This enzyme has an coordinated action with an ectoATPase and an ecto-5'-nucleotidase, leading to the production of adenosine. 20 In the tubules, the enzymes probably play a role in the salvage of nucleotides present in primary urine. The role of glomerular enzymes is not yet ¢rmly established.
Decreased PC-1 activity in type 1 diabetes could re£ect damage to proximal tubular, glomerular mesangial and epithelial cells. However, further studies are needed, both experimental and clinical.
